Skip to main content
· 10/23/1992

Barr Laboratories, Inc. v. Abbott Laboratories

Citations

  • 978 F.2d 98
  • 978 F.3d 98
  • 24 Fed. R. Serv. 3d 117
  • 1992 U.S. App. LEXIS 27245
  • 1992 WL 301618

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • recognizing that “existence of legitimate business justifications for the [exclusive dealing] contracts also supports the legality of the global contracts”
  • explaining that courts must ―evaluate the restrictiveness and the economic usefulness of the challenged practice in relation to the business factors extant in the market‖
  • explaining that courts must “evaluate the restrictiveness and the economic usefulness of the challenged practice in relation to the business factors extant in the market”
  • acknowledging that the first question is whether there is an agreement to exclusivity
  • remarking “market share of 47-50% alone [is] not enough to establish dangerous probability of success”
  • remarking on a previous decision and observing that “we condemned the district court’s practice of bifurcating trials as a general rule”

Source: CourtListener parenthetical corpus (CC0).

Judges: Hutchinson, Cowen, Weis

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.